Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Sanders

Showing results (111-120 of 154) with videos related to

Pageof 16
Sort By:
Journal of Clinical Microbiology|September 1, 1997
Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospitalE Vercauteren, P Descheemaeker, M Ieven, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1988
Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenemsJ S Bakken, C C Sanders, R B Clark, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studiesP D Lister, A Pong, S A Chartrand, et al.
European Journal of Clinical Microbiology|August 1, 1987
Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporinsD L Dworzack, M P Pugsley, C C Sanders, et al.
The Journal of Infectious Diseases|August 1, 1990
A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coliD A Weber, C C Sanders, J S Bakken, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamasesC C Sanders, W E Sanders, K S Thomson, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1987
Leakage of beta-lactamase: a second mechanism for antibiotic potentiation by amdinocillinC C Sanders, W E Sanders, R V Goering, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistanceK S Thomson, S A Chartrand, C C Sanders, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1997
Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniaeK S Thomson, S A Chartrand, C C Sanders, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1986
Evidence for multiple forms of type I chromosomal beta-lactamase in Pseudomonas aeruginosaM L Gates, C C Sanders, R V Goering, et al.
Pageof 16

Showing results (111-120 of 154) with videos related to

Sort By:
Pageof 16
Journal of Clinical Microbiology|September 1, 1997
Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospitalE Vercauteren, P Descheemaeker, M Ieven, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1988
Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenemsJ S Bakken, C C Sanders, R B Clark, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studiesP D Lister, A Pong, S A Chartrand, et al.
European Journal of Clinical Microbiology|August 1, 1987
Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporinsD L Dworzack, M P Pugsley, C C Sanders, et al.
The Journal of Infectious Diseases|August 1, 1990
A novel chromosomal TEM derivative and alterations in outer membrane proteins together mediate selective ceftazidime resistance in Escherichia coliD A Weber, C C Sanders, J S Bakken, et al.
The Journal of Antimicrobial Chemotherapy|September 1, 1989
Meropenem: activity against resistant gram-negative bacteria and interactions with beta-lactamasesC C Sanders, W E Sanders, K S Thomson, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1987
Leakage of beta-lactamase: a second mechanism for antibiotic potentiation by amdinocillinC C Sanders, W E Sanders, R V Goering, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistanceK S Thomson, S A Chartrand, C C Sanders, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1997
Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniaeK S Thomson, S A Chartrand, C C Sanders, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1986
Evidence for multiple forms of type I chromosomal beta-lactamase in Pseudomonas aeruginosaM L Gates, C C Sanders, R V Goering, et al.
Pageof 16